| Added by | mollevi |
|---|---|
| Last modified by | standudu |
| Group name | EquipeVC |
| Item Type | Journal Article |
| Title | Syringaresinol: A Renewable and Safer Alternative to Bisphenol A for Epoxy-Amine Resins |
| Creator | Janvier et al. |
| Author | M. Janvier |
| Author | L. Hollande |
| Author | A. S. Jaufurally |
| Author | M. Pernes |
| Author | R. Menard |
| Author | M. Grimaldi |
| Author | J. Beaugrand |
| Author | P. Balaguer |
| Author | P. H. Ducrot |
| Author | F. Allais |
| Abstract | A renewable bisepoxide, SYR-EPO, was prepared from syringaresinol, a naturally occurring bisphenol deriving from sinapic acid, by using a chemo-enzymatic synthetic pathway. Estrogenic activity tests revealed no endocrine disruption for syringaresinol. Its glycidylation afforded SYR-EPO with excellent yield and purity. This biobased, safe epoxy precursor was then cured with conventional and renewable diamines for the preparation of epoxy-amine resins. The resulting thermosets were thermally and mechanically characterized. Thermal analyses of these new resins showed excellent thermal stabilities (Td5 % =279-309 degrees C) and Tg ranging from 73 to 126 degrees C, almost reaching the properties of those obtained with the diglycidylether of bisphenol A (DGEBA), extensively used in the polymer industry (Td5 % =319 degrees C and Tg =150 degrees C for DGEBA/isophorone diamine resins). Degradation studies in NaOH and HCl aqueous solutions also highlighted the robustness of the syringaresinol-based resins, similar to bisphenol A (BPA). All these results undoubtedly confirmed the potential of syringaresinol as a greener and safer substitute for BPA. |
| Publication | ChemSusChem |
| Volume | 10 |
| Pages | 738-746 |
| Date | Feb 22 2017 |
| Journal Abbr | ChemSusChem |
| DOI | 10.1002/cssc.201601595 |
| ISSN | 1864-564X (Electronic) 1864-5631 (Linking) |
| Extra | 00000 |
| Tags | original |
| Date Added | 2018/11/14 - 12:10:52 |
| Date Modified | 2019/06/06 - 22:43:26 |
| Notes and Attachments | (Note) (Note) 28045228 (Attachment) |
Institut de Recherche en Cancérologie de
